All posts by: Michael Zand

About Michael Zand

Stem Cells in Sports Medicine: Ready for Prime Time? – Medscape

Continue reading

2017-07-12 NEWS

Medscape

Stem Cells in Sports Medicine: Ready for Prime Time?
Medscape
The man sitting across from me said he was desperate. Osteoarthritis was causing excruciating pain in his knee. But he had found a solution: For $18,000, a doctor in Mexico would inject stem cells from a Russian embryo. What did I think? “I don’t know

Continue reading

2017-07-12 NEWS

U.S. News & World Report

CRISPR Stocks: How to Invest in a Medical Miracle
U.S. News & World Report
In 2012, Dr. Jennifer Doudna of the University of California-Berkeley and Emmanuelle Charpentier of Umeå University in Sweden discovered what is known as the CRISPR-Cas9 genome editing technique. It was a monumental discovery: The technique is …

and more »

Continue reading

2017-07-12 NEWS

pulse

South Korea OKs First-in-Class Gene Therapy for Osteoarthritis
Genetic Engineering & Biotechnology News
South Korea’s Ministry of Food and Drug Safety said today that it has approved the country’s first gene therapy for osteoarthritis, the lead product candidate of a Maryland-based regenerative medicine company. Invossa-K Inj. was developed by …
Korea’s first gene therapy Invossa cleared to be sold in Korea …pulse
Korea approves first cell gene therapy ‘Invossa’ for degenerative arthritisAsiaOne
Ministry approves 1st domestic gene therapy product – Korea …Korea Biomedical Review
Yonhap News –Korea JoongAng Daily
all 7 news articles »
Continue reading

2017-07-12 NEWS

pulse

South Korea OKs First-in-Class Gene Therapy for Osteoarthritis
Genetic Engineering & Biotechnology News
South Korea’s Ministry of Food and Drug Safety said today that it has approved the country’s first gene therapy for osteoarthritis, the lead product candidate of a Maryland-based regenerative medicine company. Invossa-K Inj. was developed by …
Korea Approves the World’s First Cell and Gene Therapy for Knee OsteoarthritisPR Newswire (press release)
Korea’s first gene therapy Invossa cleared to be sold in Korea …pulse
Korea approves first cell gene therapy ‘Invossa’ for degenerative arthritisAsiaOne
Korea Biomedical Review –Yonhap News –Korea JoongAng Daily
all 7 news articles »
Continue reading

2017-07-12 NEWS

pulse

South Korea OKs First-in-Class Gene Therapy for Osteoarthritis
Genetic Engineering & Biotechnology News
South Korea’s Ministry of Food and Drug Safety said today that it has approved the country’s first gene therapy for osteoarthritis, the lead product candidate of a Maryland-based regenerative medicine company. Invossa-K Inj. was developed by …
Korea Approves the World’s First Cell and Gene Therapy for Knee OsteoarthritisPR Newswire (press release)
Korea’s first gene therapy Invossa cleared to be sold in Korea …pulse
Korea approves first cell gene therapy ‘Invossa’ for degenerative arthritisAsiaOne
Korea Biomedical Review –Yonhap News
all 7 news articles »